In light of the potent anti-fibrotic activities associated with the PPAR-γ pathway, and the demonstration of diminished PPAR-γ expression in various models of fibrosis, we sought to explore the possibility that deregulated fibrogenesis in SSc was accompanied by tissue-specific alterations in PPAR-γ. Here, PPARG is linked to systemic sclerosis.